Review




Structured Review

Arraystar inc gene chip arraystar lncrna v3.0 microarray
Gene Chip Arraystar Lncrna V3.0 Microarray, supplied by Arraystar inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/gene chip arraystar lncrna v3.0 microarray/product/Arraystar inc
Average 90 stars, based on 1 article reviews
gene chip arraystar lncrna v3.0 microarray - by Bioz Stars, 2026-05
90/100 stars

Images



Similar Products

90
Arraystar inc gene chip arraystar lncrna v3.0 microarray
Gene Chip Arraystar Lncrna V3.0 Microarray, supplied by Arraystar inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/gene chip arraystar lncrna v3.0 microarray/product/Arraystar inc
Average 90 stars, based on 1 article reviews
gene chip arraystar lncrna v3.0 microarray - by Bioz Stars, 2026-05
90/100 stars
  Buy from Supplier

90
Agilent technologies human lncrna microarray gene chip
Human Lncrna Microarray Gene Chip, supplied by Agilent technologies, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/human lncrna microarray gene chip/product/Agilent technologies
Average 90 stars, based on 1 article reviews
human lncrna microarray gene chip - by Bioz Stars, 2026-05
90/100 stars
  Buy from Supplier

90
Arraystar inc human lncrna array v2.0 gene chip
Identification and expression of PTC cell exosome-enriched <t>lncRNA</t> SNHG9. (A) High-throughput screening identification of PTC associated exosome lncRNAs. SNHG9 is PTC cell exosome-enriched lncRNA in TPC-1 and K-1 cells compared with Nthy-ori-3 cell. (B, C) Validation of SNHG9 overexpression in both TPC-1 and K-1 cells and their respective exosomes compared with Nthy-ori-3 cell and its exosome by qPCR. (D) Coregulation network of SNHG9 with mRNA/miRNA. SNHG9 had an interaction with autophagy related molecules. (E) Gene ontology enrichment analysis showed the highest regulation scores in autophagy and apoptosis. (F) KEGG-pathway-weighted analysis showed SNHG9 mainly targeted apoptosis and autophagy pathways. (G) SNHG9 in the PTC cell supernatant mainly derived from cell exosomes. QPCR showed significantly lower SNHG9 expression level in supernatant treated with Rnase and Triton compared with supernatant treated with only Rnase and control group. (H) QPCR confirmed no SNHG9 expression in cell supernatants after exosome extraction. (I) SNHG9 expression level between tumor and normal tissues in 70 PTC patients from FUSCC. The results were normalized to β-actin mRNA level. (J) Waterfall plot showed the distribution of SNHG9 expression level in each PTC patients from FUSCC. ***P < 0.001, data were pooled from three independent experiments. FUSCC, Fudan University Shanghai Cancer Center; PTC, papillary thyroid cancer.
Human Lncrna Array V2.0 Gene Chip, supplied by Arraystar inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/human lncrna array v2.0 gene chip/product/Arraystar inc
Average 90 stars, based on 1 article reviews
human lncrna array v2.0 gene chip - by Bioz Stars, 2026-05
90/100 stars
  Buy from Supplier

90
Agilent technologies lncrna gene chip array
Identification and expression of PTC cell exosome-enriched <t>lncRNA</t> SNHG9. (A) High-throughput screening identification of PTC associated exosome lncRNAs. SNHG9 is PTC cell exosome-enriched lncRNA in TPC-1 and K-1 cells compared with Nthy-ori-3 cell. (B, C) Validation of SNHG9 overexpression in both TPC-1 and K-1 cells and their respective exosomes compared with Nthy-ori-3 cell and its exosome by qPCR. (D) Coregulation network of SNHG9 with mRNA/miRNA. SNHG9 had an interaction with autophagy related molecules. (E) Gene ontology enrichment analysis showed the highest regulation scores in autophagy and apoptosis. (F) KEGG-pathway-weighted analysis showed SNHG9 mainly targeted apoptosis and autophagy pathways. (G) SNHG9 in the PTC cell supernatant mainly derived from cell exosomes. QPCR showed significantly lower SNHG9 expression level in supernatant treated with Rnase and Triton compared with supernatant treated with only Rnase and control group. (H) QPCR confirmed no SNHG9 expression in cell supernatants after exosome extraction. (I) SNHG9 expression level between tumor and normal tissues in 70 PTC patients from FUSCC. The results were normalized to β-actin mRNA level. (J) Waterfall plot showed the distribution of SNHG9 expression level in each PTC patients from FUSCC. ***P < 0.001, data were pooled from three independent experiments. FUSCC, Fudan University Shanghai Cancer Center; PTC, papillary thyroid cancer.
Lncrna Gene Chip Array, supplied by Agilent technologies, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/lncrna gene chip array/product/Agilent technologies
Average 90 stars, based on 1 article reviews
lncrna gene chip array - by Bioz Stars, 2026-05
90/100 stars
  Buy from Supplier

90
Agilent technologies human lncrna gene chip
Low expression of Loc490 in GC and lymph node metastasis tissue. ( A ) RNA quality testing (C: GC tissue; L: lymph node metastasis tissue; N: normal tissue adjacent to GC); ( B ) Screening for differentially expressed lncRNAs <t>using</t> <t>Agilent</t> Human <t>LncRNA</t> chip technology in normal tissues adjacent to GC, primary GC tissues and lymph node metastasis tissues; ( C ) Loc490 expression was significantly lower in lymph node metastases than in normal tissues adjacent to GC and in primary GC tissue (the other selected genes are shown in the article); ( D ) qRT-PCR results demonstrating Loc490 expression in 28 normal tissues adjacent to GC, primary GC tissues and lymph node metastasis tissues; ( E ) Expression of QKI mRNA in 28 normal tissues adjacent to GC, primary GC tissues and lymph node metastases; ( F ) Correlation analysis demonstrating that Loc490 expression was significantly positively correlated with QKI mRNA expression. Data represent the mean and SD from three experiments. **p < 0.01, ***p < 0.001.
Human Lncrna Gene Chip, supplied by Agilent technologies, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/human lncrna gene chip/product/Agilent technologies
Average 90 stars, based on 1 article reviews
human lncrna gene chip - by Bioz Stars, 2026-05
90/100 stars
  Buy from Supplier

90
Arraystar inc human lncrna array v.4.0 gene chip
Low expression of Loc490 in GC and lymph node metastasis tissue. ( A ) RNA quality testing (C: GC tissue; L: lymph node metastasis tissue; N: normal tissue adjacent to GC); ( B ) Screening for differentially expressed lncRNAs <t>using</t> <t>Agilent</t> Human <t>LncRNA</t> chip technology in normal tissues adjacent to GC, primary GC tissues and lymph node metastasis tissues; ( C ) Loc490 expression was significantly lower in lymph node metastases than in normal tissues adjacent to GC and in primary GC tissue (the other selected genes are shown in the article); ( D ) qRT-PCR results demonstrating Loc490 expression in 28 normal tissues adjacent to GC, primary GC tissues and lymph node metastasis tissues; ( E ) Expression of QKI mRNA in 28 normal tissues adjacent to GC, primary GC tissues and lymph node metastases; ( F ) Correlation analysis demonstrating that Loc490 expression was significantly positively correlated with QKI mRNA expression. Data represent the mean and SD from three experiments. **p < 0.01, ***p < 0.001.
Human Lncrna Array V.4.0 Gene Chip, supplied by Arraystar inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/human lncrna array v.4.0 gene chip/product/Arraystar inc
Average 90 stars, based on 1 article reviews
human lncrna array v.4.0 gene chip - by Bioz Stars, 2026-05
90/100 stars
  Buy from Supplier

90
Agilent technologies lncrna+mrna human gene expression microarray v4.0, 4x180k chip
Low expression of Loc490 in GC and lymph node metastasis tissue. ( A ) RNA quality testing (C: GC tissue; L: lymph node metastasis tissue; N: normal tissue adjacent to GC); ( B ) Screening for differentially expressed lncRNAs <t>using</t> <t>Agilent</t> Human <t>LncRNA</t> chip technology in normal tissues adjacent to GC, primary GC tissues and lymph node metastasis tissues; ( C ) Loc490 expression was significantly lower in lymph node metastases than in normal tissues adjacent to GC and in primary GC tissue (the other selected genes are shown in the article); ( D ) qRT-PCR results demonstrating Loc490 expression in 28 normal tissues adjacent to GC, primary GC tissues and lymph node metastasis tissues; ( E ) Expression of QKI mRNA in 28 normal tissues adjacent to GC, primary GC tissues and lymph node metastases; ( F ) Correlation analysis demonstrating that Loc490 expression was significantly positively correlated with QKI mRNA expression. Data represent the mean and SD from three experiments. **p < 0.01, ***p < 0.001.
Lncrna+Mrna Human Gene Expression Microarray V4.0, 4x180k Chip, supplied by Agilent technologies, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/lncrna+mrna human gene expression microarray v4.0, 4x180k chip/product/Agilent technologies
Average 90 stars, based on 1 article reviews
lncrna+mrna human gene expression microarray v4.0, 4x180k chip - by Bioz Stars, 2026-05
90/100 stars
  Buy from Supplier

90
CapitalBio Corporation gene expression chip lncrna + mrna human gene expression microarray v4.0
Low expression of Loc490 in GC and lymph node metastasis tissue. ( A ) RNA quality testing (C: GC tissue; L: lymph node metastasis tissue; N: normal tissue adjacent to GC); ( B ) Screening for differentially expressed lncRNAs <t>using</t> <t>Agilent</t> Human <t>LncRNA</t> chip technology in normal tissues adjacent to GC, primary GC tissues and lymph node metastasis tissues; ( C ) Loc490 expression was significantly lower in lymph node metastases than in normal tissues adjacent to GC and in primary GC tissue (the other selected genes are shown in the article); ( D ) qRT-PCR results demonstrating Loc490 expression in 28 normal tissues adjacent to GC, primary GC tissues and lymph node metastasis tissues; ( E ) Expression of QKI mRNA in 28 normal tissues adjacent to GC, primary GC tissues and lymph node metastases; ( F ) Correlation analysis demonstrating that Loc490 expression was significantly positively correlated with QKI mRNA expression. Data represent the mean and SD from three experiments. **p < 0.01, ***p < 0.001.
Gene Expression Chip Lncrna + Mrna Human Gene Expression Microarray V4.0, supplied by CapitalBio Corporation, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/gene expression chip lncrna + mrna human gene expression microarray v4.0/product/CapitalBio Corporation
Average 90 stars, based on 1 article reviews
gene expression chip lncrna + mrna human gene expression microarray v4.0 - by Bioz Stars, 2026-05
90/100 stars
  Buy from Supplier

Image Search Results


Identification and expression of PTC cell exosome-enriched lncRNA SNHG9. (A) High-throughput screening identification of PTC associated exosome lncRNAs. SNHG9 is PTC cell exosome-enriched lncRNA in TPC-1 and K-1 cells compared with Nthy-ori-3 cell. (B, C) Validation of SNHG9 overexpression in both TPC-1 and K-1 cells and their respective exosomes compared with Nthy-ori-3 cell and its exosome by qPCR. (D) Coregulation network of SNHG9 with mRNA/miRNA. SNHG9 had an interaction with autophagy related molecules. (E) Gene ontology enrichment analysis showed the highest regulation scores in autophagy and apoptosis. (F) KEGG-pathway-weighted analysis showed SNHG9 mainly targeted apoptosis and autophagy pathways. (G) SNHG9 in the PTC cell supernatant mainly derived from cell exosomes. QPCR showed significantly lower SNHG9 expression level in supernatant treated with Rnase and Triton compared with supernatant treated with only Rnase and control group. (H) QPCR confirmed no SNHG9 expression in cell supernatants after exosome extraction. (I) SNHG9 expression level between tumor and normal tissues in 70 PTC patients from FUSCC. The results were normalized to β-actin mRNA level. (J) Waterfall plot showed the distribution of SNHG9 expression level in each PTC patients from FUSCC. ***P < 0.001, data were pooled from three independent experiments. FUSCC, Fudan University Shanghai Cancer Center; PTC, papillary thyroid cancer.

Journal: Frontiers in Oncology

Article Title: SNHG9, a Papillary Thyroid Cancer Cell Exosome-Enriched lncRNA, Inhibits Cell Autophagy and Promotes Cell Apoptosis of Normal Thyroid Epithelial Cell Nthy-ori-3 Through YBOX3/P21 Pathway

doi: 10.3389/fonc.2021.647034

Figure Lengend Snippet: Identification and expression of PTC cell exosome-enriched lncRNA SNHG9. (A) High-throughput screening identification of PTC associated exosome lncRNAs. SNHG9 is PTC cell exosome-enriched lncRNA in TPC-1 and K-1 cells compared with Nthy-ori-3 cell. (B, C) Validation of SNHG9 overexpression in both TPC-1 and K-1 cells and their respective exosomes compared with Nthy-ori-3 cell and its exosome by qPCR. (D) Coregulation network of SNHG9 with mRNA/miRNA. SNHG9 had an interaction with autophagy related molecules. (E) Gene ontology enrichment analysis showed the highest regulation scores in autophagy and apoptosis. (F) KEGG-pathway-weighted analysis showed SNHG9 mainly targeted apoptosis and autophagy pathways. (G) SNHG9 in the PTC cell supernatant mainly derived from cell exosomes. QPCR showed significantly lower SNHG9 expression level in supernatant treated with Rnase and Triton compared with supernatant treated with only Rnase and control group. (H) QPCR confirmed no SNHG9 expression in cell supernatants after exosome extraction. (I) SNHG9 expression level between tumor and normal tissues in 70 PTC patients from FUSCC. The results were normalized to β-actin mRNA level. (J) Waterfall plot showed the distribution of SNHG9 expression level in each PTC patients from FUSCC. ***P < 0.001, data were pooled from three independent experiments. FUSCC, Fudan University Shanghai Cancer Center; PTC, papillary thyroid cancer.

Article Snippet: Next, we used the Arraystar Human LncRNA Array v2.0 gene chip to compare expression profile data of lncRNAs in Nthy-ori-3, TPC-1 and K-1 cells and their respective exosomes.

Techniques: Expressing, High Throughput Screening Assay, Biomarker Discovery, Over Expression, Derivative Assay, Control, Extraction

Low expression of Loc490 in GC and lymph node metastasis tissue. ( A ) RNA quality testing (C: GC tissue; L: lymph node metastasis tissue; N: normal tissue adjacent to GC); ( B ) Screening for differentially expressed lncRNAs using Agilent Human LncRNA chip technology in normal tissues adjacent to GC, primary GC tissues and lymph node metastasis tissues; ( C ) Loc490 expression was significantly lower in lymph node metastases than in normal tissues adjacent to GC and in primary GC tissue (the other selected genes are shown in the article); ( D ) qRT-PCR results demonstrating Loc490 expression in 28 normal tissues adjacent to GC, primary GC tissues and lymph node metastasis tissues; ( E ) Expression of QKI mRNA in 28 normal tissues adjacent to GC, primary GC tissues and lymph node metastases; ( F ) Correlation analysis demonstrating that Loc490 expression was significantly positively correlated with QKI mRNA expression. Data represent the mean and SD from three experiments. **p < 0.01, ***p < 0.001.

Journal: Aging (Albany NY)

Article Title: Long non-coding RNA Loc490 inhibits gastric cancer cell proliferation and metastasis by upregulating RNA-binding protein Quaking

doi: 10.18632/aging.103876

Figure Lengend Snippet: Low expression of Loc490 in GC and lymph node metastasis tissue. ( A ) RNA quality testing (C: GC tissue; L: lymph node metastasis tissue; N: normal tissue adjacent to GC); ( B ) Screening for differentially expressed lncRNAs using Agilent Human LncRNA chip technology in normal tissues adjacent to GC, primary GC tissues and lymph node metastasis tissues; ( C ) Loc490 expression was significantly lower in lymph node metastases than in normal tissues adjacent to GC and in primary GC tissue (the other selected genes are shown in the article); ( D ) qRT-PCR results demonstrating Loc490 expression in 28 normal tissues adjacent to GC, primary GC tissues and lymph node metastasis tissues; ( E ) Expression of QKI mRNA in 28 normal tissues adjacent to GC, primary GC tissues and lymph node metastases; ( F ) Correlation analysis demonstrating that Loc490 expression was significantly positively correlated with QKI mRNA expression. Data represent the mean and SD from three experiments. **p < 0.01, ***p < 0.001.

Article Snippet: We used an Agilent Human LncRNA gene chip to compare the lncRNA and mRNA levels in GC and metastatic lymph node tissues with those in normal tissues adjacent to the GC.

Techniques: Expressing, Quantitative RT-PCR